Patent · US Active

Organic compounds

US8097617B2 · kind B2 · utility

2Cited by

1References

17Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Daniel Baeschlin · Arlesheim, CH
Nils Ostermann · Binzen, DE
Francois Gessier · Illfurth, FR
Finton Sirockin · Blotzheim, FR
Kenji Namoto · Basel, CH

Key dates

Filing date	Mar 29, 2007
Grant date	Jan 17, 2012
Priority date	—
Expiry date	Jun 10, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

New compounds of the Formula (I):for the treatment of non-insulin-dependent diabetes mellitus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.